DK0484112T3 - Anvendelse af lithium ved behandlingen eller profylakse af Molluscum contagiosum - Google Patents

Anvendelse af lithium ved behandlingen eller profylakse af Molluscum contagiosum

Info

Publication number: DK0484112T3
Authority: DK; Denmark
Prior art keywords: prophylaxis; treatment; molluscum contagiosum; lithium; lithium compound
Prior art date: 1990-10-31

Application number

DK91309994.1T

Other languages

English (en)

Inventor

David Frederick Horrobin

Original Assignee

Scotia Holdings Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-10-31

Filing date

1991-10-30

Publication date

1995-09-18

1991-10-30 Application filed by Scotia Holdings Plc filed Critical Scotia Holdings Plc

1995-09-18 Application granted granted Critical

1995-09-18 Publication of DK0484112T3 publication Critical patent/DK0484112T3/da

Links

208000008588 molluscum contagiosum Diseases 0.000 title abstract 2
238000011321 prophylaxis Methods 0.000 title abstract 2
238000011282 treatment Methods 0.000 title abstract 2
WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 title 1
229910052744 lithium Inorganic materials 0.000 title 1
150000002642 lithium compounds Chemical class 0.000 abstract 2
229940124091 Keratolytic Drugs 0.000 abstract 1
239000003795 chemical substances by application Substances 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
239000003937 drug carrier Substances 0.000 abstract 1
230000001530 keratinolytic effect Effects 0.000 abstract 1
238000004519 manufacturing process Methods 0.000 abstract 1
230000035515 penetration Effects 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
239000000546 pharmaceutical excipient Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Inorganic Chemistry (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Dermatology (AREA)
Oil, Petroleum & Natural Gas (AREA)
Bioinformatics & Cheminformatics (AREA)
Communicable Diseases (AREA)
Virology (AREA)
Oncology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Materials For Medical Uses (AREA)
Glass Compositions (AREA)

DK91309994.1T 1990-10-31 1991-10-30 Anvendelse af lithium ved behandlingen eller profylakse af Molluscum contagiosum DK0484112T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB909023701A GB9023701D0 (en)	1990-10-31	1990-10-31	Medical treatment

Publications (1)

Publication Number	Publication Date
DK0484112T3 true DK0484112T3 (da)	1995-09-18

Family

ID=10684665

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK91309994.1T DK0484112T3 (da)	1990-10-31	1991-10-30	Anvendelse af lithium ved behandlingen eller profylakse af Molluscum contagiosum

Country Status (11)

Country	Link
US (1)	US5223271A (da)
EP (1)	EP0484112B1 (da)
JP (1)	JPH06263644A (da)
AT (1)	ATE126061T1 (da)
AU (1)	AU645359B2 (da)
CA (1)	CA2052246A1 (da)
DE (1)	DE69111974T2 (da)
DK (1)	DK0484112T3 (da)
GB (1)	GB9023701D0 (da)
GR (1)	GR3017855T3 (da)
IE (1)	IE71171B1 (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7404967B2 (en)	1994-12-21	2008-07-29	Cosmederm, Inc.	Topical product formulations containing strontium for reducing skin irritation
US5756107A (en) *	1994-12-21	1998-05-26	Cosmederm Technologies	Formulations and methods for reducing skin irritation
US5840711A (en) *	1995-06-21	1998-11-24	University Of Kentucky Research Foundation	Compositions containing lithium inorganic salts and anti-viral drugs and method of treating viral infections such as acquired immunodeficiency syndrome
WO1999018797A1 (en) *	1997-10-09	1999-04-22	Emory University	Method and devices for transdermal delivery of lithium
FR2783424B1 (fr) *	1998-09-03	2002-10-04	Labcatal	Utilisation du gluconate de lithium dans la fabrication d'un medicament pour le traitement de l'herpes et de la dermite seborrheique
EP1242096B1 (en) *	1999-12-30	2005-10-12	Henderson Morley Research and Development Limited	Pharmaceutucal compositions for the treatment of dna viral infections comprising a loop diuretic and lithium
ES2164018B1 (es) *	2000-05-26	2003-06-16	Inst De Salud Carlos Iii	Empleo de una sal de litio en la elaboracion de un medicamento para el tratamiento de la infeccion causada por el virus respiratorio sincitial humano (vrdh)
US7311928B2 (en) *	2003-12-09	2007-12-25	Briant Burke	Topical compositions containing tea tree oil for treatment of viral lesions
EP2143421A1 (en) *	2008-07-07	2010-01-13	Almirall Hermal GmbH	Topical composition for the treatment of actinic keratosis
AU2011338530B2 (en)	2010-12-06	2017-06-15	Follica, Inc.	Methods for treating baldness and promoting hair growth
WO2012125941A1 (en) *	2011-03-17	2012-09-20	Follica, Inc.	Lithium treatment for microbial infections
RU2715103C2 (ru) *	2013-05-03	2020-02-27	Липидор Аб	Местная композиция и носитель для введения фармацевтически или косметически активных ингредиентов
US20220347208A1 (en) *	2019-06-19	2022-11-03	Carl Ganio	Formulations using lithium to treat gout arthropathy

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3639625A (en) *	1967-07-13	1972-02-01	Lewis Sherwin	Compositions containing lithium succinate
US4396452A (en)	1978-12-21	1983-08-02	Monsanto Company	Process for point-bonding organic fibers
JPS5590505A (en)	1978-12-29	1980-07-09	Kureha Chem Ind Co Ltd	Carboxyalkylchitin and preparation of deacetylated product thereof
US4328243A (en) *	1981-04-07	1982-05-04	Horrobin David F	Manic-depressive illnesses
US4386072A (en) *	1981-06-26	1983-05-31	Horrobin David F	Treatment of disorders of inflammation and immunity and disorders associated with smooth muscle spasm and compositions therefor
AU556817B2 (en) *	1982-02-03	1986-11-20	Efamol Limited	Topical application of a lithium salt and dihomo-alpha- linolenic acid
GB8318912D0 (en) *	1983-07-13	1983-08-17	Horrobin D F	Compositions for treatment of skin/hair
GB8320203D0 (en) *	1983-07-27	1983-09-01	Horrobin D F	Anti-viral compositions
GB8601915D0 (en) *	1986-01-27	1986-03-05	Efamol Ltd	Pharmaceutical compositions
EP0289204B1 (en) *	1987-04-27	1991-07-17	Efamol Holdings Plc	Lithium salt-containing pharmaceutical compositions
GB8719988D0 (en) *	1987-08-25	1987-09-30	Efamol Ltd	Chemical compounds

1990
- 1990-10-31 GB GB909023701A patent/GB9023701D0/en active Pending
1991
- 1991-09-24 US US07/765,008 patent/US5223271A/en not_active Expired - Fee Related
- 1991-09-25 CA CA002052246A patent/CA2052246A1/en not_active Abandoned
- 1991-10-29 JP JP3282818A patent/JPH06263644A/ja active Pending
- 1991-10-30 EP EP91309994A patent/EP0484112B1/en not_active Expired - Lifetime
- 1991-10-30 IE IE378791A patent/IE71171B1/en not_active IP Right Cessation
- 1991-10-30 DK DK91309994.1T patent/DK0484112T3/da active
- 1991-10-30 DE DE69111974T patent/DE69111974T2/de not_active Expired - Fee Related
- 1991-10-30 AU AU86873/91A patent/AU645359B2/en not_active Ceased
- 1991-10-30 AT AT91309994T patent/ATE126061T1/de not_active IP Right Cessation
1995
- 1995-10-25 GR GR950402959T patent/GR3017855T3/el unknown

Also Published As

Publication number	Publication date
AU645359B2 (en)	1994-01-13
ATE126061T1 (de)	1995-08-15
CA2052246A1 (en)	1992-05-01
IE71171B1 (en)	1997-01-29
DE69111974T2 (de)	1996-01-04
US5223271A (en)	1993-06-29
EP0484112A2 (en)	1992-05-06
GB9023701D0 (en)	1990-12-12
GR3017855T3 (en)	1996-01-31
EP0484112A3 (en)	1992-07-08
EP0484112B1 (en)	1995-08-09
JPH06263644A (ja)	1994-09-20
IE913787A1 (en)	1992-05-22
DE69111974D1 (de)	1995-09-14
AU8687391A (en)	1992-05-07

Publication	Publication Date	Title
BR9306841A (pt)	1998-12-08	Composição farmacêutica processo para proporcionar um tratamento anti-histamínico o qual não induz qualquer arritmia cardíaca significativa em um paciente ser humano e uso de uma composição para a mnaufactura de um medicamento para uso em um tratamento anti-histamínico
NO931267L (no)	1993-05-05	Fremgangsmaate for behandling eller forebyggelse av type 1diabetes ved oral administrering av insulin
KR950002785A (ko)	1995-02-16	골량을 증가시키기 위한 부갑상선 호르몬 및 랄옥시펜
ES554967A0 (es)	1987-12-16	Un procedimiento para preparar una formulacion farmaceutica que contiene un 2'3'-didesoxi-nucleosido.
DK275488D0 (da)	1988-05-19	Indolonderivater
BR9303469A (pt)	1994-03-22	Conjugado de interferon,composto,processo de preparacao de um conjugado de interferon,use e composicoes farmaceuticas
ATE75945T1 (de)	1992-05-15	Pharmazeutische zubereitung zur behandlung des diabetes mellitus.
ES2090244T3 (es)	1996-10-16	Procedimiento para prevenir, estabilizar u ocasionar la regresion de la aterosclerosis usando una combinacion de un medicamento para disminuir el colesterol y un inhibidor de la ace.
DK0484112T3 (da)	1995-09-18	Anvendelse af lithium ved behandlingen eller profylakse af Molluscum contagiosum
DE69333387D1 (de)	2004-02-19	Pharmazeutische Zusammensetzungen enthaltend Norastemizol.
DK0629400T3 (da)	2000-02-14	Idebenon-holdige præparater til behandling af Alzheimer's syge
DE69133077D1 (de)	2002-08-29	Herstellung von ST1435 enthaltenden pharmazeutischen Zusammensetzungen zur topischen Verwendung
ATE334589T1 (de)	2006-08-15	Anti-arrhythmische zusammensetzungen und behandlungsverfahren
DK347289D0 (da)	1989-07-13	Terapeutiske forbindelser
BR9712614A (pt)	1999-10-26	Composição farmacêutica,processos para aumentar e manter a homogeneidade de uma composição farmac&eutica,para tratar,reverter,reduzir ou inibir infeccões retrovirais e para preparação de uma composição farmacêutica,uso de lamivudina ou de um derivado farmaceuticamenete aceitável da mesma,de zidovudina,ou de um derivado farmaceuticamente aceitável da mesma e de um agente de deslizamento farmaceuticamente aceitável,e, artigo de amnufatura.
SE8804640D0 (sv)	1988-12-23	Medicament comprising cyclolinopeptide a
NO993921D0 (no)	1999-08-13	Medikament mot infertilitet og for ökt fertilitet
ES2120966T3 (es)	1998-11-16	1'-aminoespiro(isoquinolino-4(1h),3'-pirrolidino)-1,2',3,5'(2h)-tetronas y analogos de las mismas utiles como inhibidores de la aldosa reductasa in vivo.
MX9303074A (es)	1994-01-31	Uso de la (e)-2-(p-fluorofenetil)-3-fluoroalilamina en el tratamiento de la enfermedad de elzheimer.
SE8903117D0 (sv)	1989-09-22	Laekemedel omfattande antamanid
IT1243368B (it)	1994-06-10	Uso del bendazac e dei suoi sali farmaceuticamente accettabili
UY26292A1 (es)	2000-10-31	Micofenolato mofetilo en asociacion con peg-ifn-a ley 17164